Influence of increasing elastic ankle exoskeleton stiffness on the metabolic cost of soleus muscle force
The metabolic energy utilized by leg muscles to generate ground force is a primary determinant of 4 metabolic rate during locomotion 1-10 . In fact, the relationship between metabolic rate and the rate of 5 muscle force production during human walking has been formalized by Griffin et al 8 and is recapitulated 6 here in a slightly different form to focus on the soleus muscle during stance phase (Eq. S1 below); rather 7 than all of the leg extensor muscles during ground contact (Eq. 3 in Griffin et al 8 ). Namely, we assume 8 that the soleus muscle consumes metabolic energy at a rate (̇) that is proportional to its rate ( 1 ) of 9 active muscle volume ( ); the volume of active muscle used to generate force per unit activation time 10 ( ) (Eq. S1) 11 ̇= • (Eq. S1) 12 The constant ' ' is the amount of soleus metabolic energy consumed per unit muscle volume (J cm -3 ). to the zero exoskeleton stiffness condition (Table 2) . Our finding that changes in muscle activation well-33 explains metabolic rate during walking with exoskeletons is supported by previous work using powered 34 ankle exoskeletons (see Fig. 9 , Jackson et al. 13 ). Furthermore, if the correlation is causal, a linear fit to 35 the Δ net metabolic rate (W kg -1 ) versus Δ soleus activation rate (unitless s -1 ) data suggest that for this 36 exoskeleton a unit reduction in soleus activation rate should yield a ~1.3 W kg -1 reduction in whole-body 37 net metabolic rate ( Fig. 5 ). In theory this was achieved by reducing and/or increasing . When linking muscle total force ( ) and its activation (act ~= ), it is important to consider 55 whether all of the force is generated by active contractile machinery. For example, it is well known that 56 when a muscle is stretched beyond its optimal length (l0) some of the total muscle force ( ) is 57 contributed by structures in parallel with the contractile apparatus that can produce muscle force 58 passively ( ) (Fig. 4B, dashed Even for walking with the stiffest exoskeletons we tested (kexo=250 Nm rad -1 ), we estimate that passive 62 muscle force was likely not a factor (Fig. 4C ). We note however, that for elastic ankle exoskeletons 63 stiffer than 250 Nm rad -1 , passive forces may contribute due to the trend toward increasing soleus 64 operating lengths (Fig. 4A) . Given that in this study active and total soleus muscle force were near 65 equivalent ( ≅ ) (Eq. S4), any reduction in due to the exoskeleton should be captured 66 by changes in . Our analysis indicated a moderate correlation (R 2 =0.42) between changes in 67 soleus total force rate during early stance (Fig. 3A ) (see Methods for details on rate calculations) and 68 changes in whole-body net metabolic rate with respect to the zero exoskeleton stiffness condition (Table   69 2). Since muscle force does not always reflect muscle activation (Eqs. S4-S6) 17 , in addition to reducing 85 soleus force rate, elastic ankle exoskeletons may also act to reduce activation by improving the economy 86 of muscle force production. Combining Eq. 4 and 6, we see that, independent of the muscle force 87 required, exoskeletons could shift soleus' operating point on the F-L and/or F-V curve to a point with 88 greater force capacity (e.g., up to or beyond the optimal length, lo or closer to isometric) yielding 89 improved economy by increasing the muscle force per unit muscle activation (Eq. S7) (i.e., by 90 decreasing the activation and thus metabolic energy consumed per unit force [18] [19] [20] [21] Indeed, our data indicate that during early stance, increasing exoskeleton stiffness increased soleus 93 operating length, pushing it toward its optimal length, l0 (Fig. 4C) , and increasing its force per activation 94 (Fig. 4B ). However, increasing exoskeleton stiffness also increased soleus shortening velocity in late 95 stance pushing it toward vmax (Fig. 4F ) and decreasing its force per activation (Fig. 4E ).
97
It is difficult to disentangle the effects of increasing ankle exoskeleton stiffness on soleus F-L and F-V 98 effects as they relate to metabolic rate, because they tend to counteract each other's effects. This trade-99 off is perhaps reflected in the lack of correlation between changes in force per activation during stance 100 and changes in whole-body net metabolic rate (Table 2) . Nevertheless, our data suggest that the F-V 101 driven decrease in soleus force per activation in late stance (Fig. 4E,F) outweighed the F-L driven 102 increase in soleus force per activation in early stance (Fig. 4B,C) and contributed to the observed 103 increase in both stance phase soleus muscle activation rate ( Fig. 3B ) and whole-body net metabolic rate 104 ( Fig. 2A) for the stiffest ankle exoskeletons. This notion is supported by a moderate negative correlation 105 (R 2 =0.53) between changes in soleus force rate in late stance (Fig. 3A) and changes in whole-body net 106 metabolic rate ( Fig. 2A) with respect to the zero exoskeleton stiffness condition (Table 2) . That is, the 107 stiffest exoskeletons, which also yielded the highest whole-body net metabolic rates were associated 108 with reduced soleus muscle force rates in late stance (Fig. 3A) ; a consequence that is likely derived from 109 poor F-V contractile conditions (Fig. 4F) . As a result, in late stance, markedly reduced soleus force rate 110 ( Fig. 3A) did not translate to reductions in soleus muscle activation rate (Fig. 3B ). This suggests that for 111 the stiffest exoskeletons, reduced force capacity (i.e., force per activation) (Eq. S7) (Figs. 4B,E) 112 outweighed reduced force demand (Eqs. S3-S4) ( Fig. 3A) and increased whole-body net metabolic rate 113 ( Fig. 2A) . Taken together, these data support our hypothesis that a trade-off between reduced soleus 114 force demand and a shift to soleus fascicle contractile conditions that are less economical for force 
